The protein used as an example in the study, anaplastic lymphoma kinase (ALK), is not yet validated and classified as a CTA/TAA at present (55), but this protein has a potential to be a localized biomarker for lung cancer. The gene discussed is ALK; the disease is lung carcinoma.